Literature DB >> 7599324

Serum amino acid disturbance in multiple myeloma with hyperammonemia.

H Matsuzaki1, H Hata, T Sonoki, F Matsuno, N Kuribayashi, M Yoshida, A Nagasaki, H Murata, S Fujiyama, K Takatsuki.   

Abstract

From October 1987 to November 1993 we evaluated the serum levels of ammonia and amino acids in 85 patients with multiple myeloma. Six of the 85 cases of multiple myeloma demonstrated hyperammonemia and none of the known causes of hyperammonemia, such as liver failure, could be identified in these patients. All six patients also showed serum amino acid disturbances and conscious disorders in various degrees. In this study we compared these abnormalities in multiple myeloma with those in chronic liver failure (n = 14), the basic diseases of which were liver cirrhosis in six cases and liver cirrhosis complicated hepatocellular carcinoma in eight cases. There was a marked difference in the levels of individual serum amino acids between these two groups. The level of glycine was significantly higher in the multiple myeloma group (P < 0.001); on the other hand, that of tyrosine was significantly higher in the liver failure group (P < 0.005). The histidine (P < 0.005) and arginine (P < 0.005) levels were lower in the myeloma group. The ratio of glycine to tyrosine (Gly/Tyr) was 16.7 +/- 4.85 in the myeloma group and 1.7 +/- 0.12 in the liver failure group. The ratio of glycine to tyrosine was an important criterion for differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7599324     DOI: 10.1016/0925-5710(95)00359-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  2 in total

1.  An unusual cause of anemia and encephalopathy.

Authors:  Sanjeev Kumar Sharma; Dharma Choudhary; Anil Handoo; Gaurav Dhamija; Gaurav Kharya; Vipin Khandelwal; Mayank Dhamija; Sweta Kothari
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-05-01       Impact factor: 2.576

Review 2.  High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations.

Authors:  Melania Carlisi; Salvatrice Mancuso; Rosalia Lo Presti; Sergio Siragusa; Gregorio Caimi
Journal:  Cancers (Basel)       Date:  2022-01-26       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.